Amputation in diabetic foot ulcer: A treatment dilemma.

Raden Andri Primadhi, Rani Septrina, Putie Hapsari, Maya Kusumawati
Author Information
  1. Raden Andri Primadhi: Department of Orthopaedics and Traumatology, Universitas Padjadjaran/Hasan Sadikin Hospital, Bandung 40161, Indonesia. randri@unpad.ac.id.
  2. Rani Septrina: Division of Plastic Reconstructive and Aesthetic Surgery, Department of Surgery, Universitas Padjadjaran/Hasan Sadikin Hospital, Bandung 40161, Indonesia.
  3. Putie Hapsari: Division of Vascular and Endovascular Surgery, Department of Surgery, Universitas Padjadjaran/Hasan Sadikin Hospital, Bandung 40161, Indonesia.
  4. Maya Kusumawati: Internal Medicine, Universitas Padjadjaran/Hasan Sadikin Hospital, Bandung 40161, Indonesia.

Abstract

Diabetic foot is a clinical manifestation of diabetes with a wide range of symptoms, including ulceration, osteomyelitis, osteoarticular destruction, and gangrene, as a consequence of advanced disease. Some diabetic foot cases present general indications for amputation, including dead limb, threat to the patient's life, pain, loss of function, or nuisance. Various tools have been introduced to help decision-making in amputation for diabetic foot. However, it remains a conundrum because diabetic foot involves multiple pathomechanisms and factors that hinder its outcomes. Sociocultural issues often impede treatment from the patient's side. We reviewed different perspectives in diabetic foot management, particularly related to amputation. In addition to deciding whether to amputate, physicians should address amputation level, timing, and ways to avoid patient deconditioning. Surgeons should not be autocratic in these circumstances and should be aware of beneficence and maleficence when considering whether to amputate. The main goal should be improving the patients' quality of life rather than preserving the limb as much as possible.

Keywords

References

  1. J Wound Ostomy Continence Nurs. 2013 Nov-Dec;40(6):585-9 [PMID: 24202221]
  2. World J Diabetes. 2015 Jul 10;6(7):961-9 [PMID: 26185603]
  3. Clin Microbiol Infect. 2015 Sep;21 Suppl 2:S27-32 [PMID: 26198368]
  4. World J Diabetes. 2017 Apr 15;8(4):135-142 [PMID: 28465790]
  5. Diabetes Res Clin Pract. 2014 Sep;105(3):336-43 [PMID: 25023217]
  6. Eur J Vasc Endovasc Surg. 2007 Apr;33(4):453-60 [PMID: 17196848]
  7. J Clin Orthop Trauma. 2016 Oct-Dec;7(4):242-247 [PMID: 27857497]
  8. Curr Diabetes Rev. 2021;17(1):55-62 [PMID: 32091343]
  9. J Orthop Trauma. 1994 Aug;8(4):282-5 [PMID: 7965288]
  10. Asian J Surg. 2022 Jan;45(1):68-78 [PMID: 34376365]
  11. Adv Wound Care (New Rochelle). 2021 Dec;10(12):685-698 [PMID: 32870777]
  12. Prosthet Orthot Int. 2015 Feb;39(1):29-39 [PMID: 25614499]
  13. Sci Rep. 2021 Jan 26;11(1):2189 [PMID: 33500533]
  14. Diabetes Metab Res Rev. 2016 Jan;32 Suppl 1:136-44 [PMID: 26342204]
  15. J Reconstr Microsurg. 2021 Jan;37(1):12-16 [PMID: 32791540]
  16. Semin Intervent Radiol. 2015 Jun;32(2):108-22 [PMID: 26038619]
  17. Br J Sports Med. 2003 Feb;37(1):30-5 [PMID: 12547740]
  18. World J Diabetes. 2015 Apr 15;6(3):432-44 [PMID: 25897354]
  19. BMC Geriatr. 2020 Mar 4;20(1):87 [PMID: 32131742]
  20. J Cardiovasc Dis Res. 2013 Jun;4(2):79-83 [PMID: 24027360]
  21. Circ Cardiovasc Qual Outcomes. 2020 Jul;13(7):e006399 [PMID: 32615798]
  22. Prim Care Companion J Clin Psychiatry. 2007;9(4):303-8 [PMID: 17934555]
  23. Ann Transl Med. 2019 Sep;7(18):485 [PMID: 31700921]
  24. Drugs. 2010 Oct 1;70(14):1785-97 [PMID: 20836573]
  25. Foot Ankle Int. 2013 Aug;34(8):1097-9 [PMID: 23493775]
  26. Int Wound J. 2011 Jun;8(3):301-5 [PMID: 21545407]
  27. Diabetes Metab Syndr Obes. 2018 Mar 07;11:35-43 [PMID: 29563821]
  28. Int J Qual Stud Health Well-being. 2022 Dec;17(1):2009202 [PMID: 34963426]
  29. J Atheroscler Thromb. 2018 Jan 1;25(1):27-39 [PMID: 28966336]
  30. Diabetologia. 2008 Nov;51(11):1962-70 [PMID: 18719880]
  31. J Clin Med. 2021 Sep 02;10(17): [PMID: 34501432]
  32. Int Wound J. 2020 Dec;17(6):1996-2004 [PMID: 33021061]
  33. Circ Res. 2006 Jan 6;98(1):4-6 [PMID: 16397150]
  34. Eur Rev Med Pharmacol Sci. 2019 Apr;23(2 Suppl):26-37 [PMID: 30977868]
  35. Prosthet Orthot Int. 2010 Mar;34(1):31-6 [PMID: 20196687]
  36. World J Orthop. 2021 Feb 18;12(2):61-68 [PMID: 33614425]
  37. Fibrogenesis Tissue Repair. 2012 Aug 01;5(1):13 [PMID: 22853690]
  38. Semin Intervent Radiol. 2014 Dec;31(4):330-7 [PMID: 25435658]
  39. Diabetes Care. 2006 May;29(5):988-92 [PMID: 16644625]
  40. Int J Mol Sci. 2020 Mar 06;21(5): [PMID: 32155866]

Word Cloud

Created with Highcharts 10.0.0footdiabeticamputationDiabeticincludinglimbpatient'slifetreatmentwhetheramputateAmputationclinicalmanifestationdiabeteswiderangesymptomsulcerationosteomyelitisosteoarticulardestructiongangreneconsequenceadvanceddiseasecasespresentgeneralindicationsdeadthreatpainlossfunctionnuisanceVarioustoolsintroducedhelpdecision-makingHoweverremainsconundruminvolvesmultiplepathomechanismsfactorshinderoutcomesSocioculturalissuesoftenimpedesiderevieweddifferentperspectivesmanagementparticularlyrelatedadditiondecidingphysiciansaddressleveltimingwaysavoidpatientdeconditioningSurgeonsautocraticcircumstancesawarebeneficencemaleficenceconsideringmaingoalimprovingpatients'qualityratherpreservingmuchpossibleulcer:dilemmaDecision-makingPerspectiveUlcer

Similar Articles

Cited By